Index of reports
> Cases with Anaemia (44)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Neulasta (Pegfilgrastim) where reactions include anaemia. The selected reports were submitted to the FDA during the sample period of about a year.
Reports 1 - 30 of 44 Next >>
Possible Neulasta side effects in female
Reported by a individual with unspecified qualification from United States on 2012-07-10
Patient: female, weighing 85.0 kg (187.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Paclitaxel
Dosage: 262 mg
Ifosfamide
Dosage: 9.3 g
Neulasta
Dosage: 6 mg
Possible Neulasta side effects in male
Reported by a consumer/non-health professional from Germany on 2012-07-09
Patient: male
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Neulasta
Dosage: 6 mg, unk
Indication: B-Cell Lymphoma
Start date: 2012-04-06
End date: 2012-04-06
Rituximab
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-02
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Prednisolone
Dosage: 500 mg, qd
Administration route: Oral
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-06
Other drugs received by patient: Novalgin / 00169801 /; Morphine Sulfate; Pantoprazole; Dipyrone TAB; Metoclopramide; Acyclovir
Possible Neulasta side effects in 65 year old female
Reported by a physician from Netherlands on 2012-07-06
Patient: 65 year old female, weighing 70.0 kg (154.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 88 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Vincristine
Dosage: 2 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Neulasta
Dosage: 6 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-26
Rituximab
Dosage: 660 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Cyclophosphamide
Dosage: 1310 mg, unk
Indication: Malignant Lymphoid Neoplasm
Start date: 2012-05-25
Possible Neulasta side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-04
Patient: female, weighing 90.0 kg (198.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Topotecan
Dosage: 1.25 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-01
Neulasta
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Sorafenib; Placebo; Darbepoetin Alfa; Filgrastim
Possible Neulasta side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-07-04
Patient: female, weighing 84.5 kg (185.9 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Indication: Product Used FOR Unknown Indication
Topotecan
Dosage: 1.25 mg, qd
Start date: 2012-03-26
End date: 2012-06-01
Other drugs received by patient: Sorafenib; Placebo; Filgrastim; Darbepoetin Alfa
Possible Neulasta side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-24
Patient: female, weighing 90.0 kg (198.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Topotecan
Dosage: 1.25 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-01
Neulasta
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Sorafenib; Filgrastim; Darbepoetin Alfa; Placebo
Possible Neulasta side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-24
Patient: female, weighing 84.5 kg (185.9 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Topotecan
Dosage: 1.25 mg, qd
Start date: 2012-03-26
End date: 2012-06-01
Neulasta
Indication: Product Used FOR Unknown Indication
Other drugs received by patient: Placebo; Darbepoetin Alfa; Sorafenib; Filgrastim
Possible Neulasta side effects in female
Reported by a physician from Germany on 2012-06-05
Patient: female, weighing 90.0 kg (198.0 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Indication: Product Used FOR Unknown Indication
Topotecan
Dosage: 1.25 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-05-28
End date: 2012-06-01
Other drugs received by patient: Placebo; Filgrastim; Sorafenib; Darbepoetin Alfa
Possible Neulasta side effects in female
Reported by a health professional (non-physician/pharmacist) from Germany on 2012-06-04
Patient: female, weighing 84.5 kg (185.9 pounds)
Reactions: Anaemia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Indication: Product Used FOR Unknown Indication
Topotecan
Dosage: 1.25 mg, qd
Start date: 2012-03-26
End date: 2012-06-01
Other drugs received by patient: Filgrastim; Darbepoetin Alfa; Placebo; Sorafenib
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-05-29
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Other drugs received by patient: Pinex; Sulphamethizole; Valacyclovir Hydrochloride; Omeprazole
Possible Neulasta side effects in
Reported by a physician from Greece on 2012-05-10
Patient: , weighing 40.0 kg (88.0 pounds)
Reactions: Bone Pain, Anaemia, Febrile Neutropenia, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Neulasta
Possible Neulasta side effects in 87 year old female
Reported by a physician from Germany on 2012-05-03
Patient: 87 year old female
Reactions: Seborrhoeic Dermatitis, Coagulopathy, Febrile Infection, Capillary Leak Syndrome, Overdose, Thrombocytopenia, Sinusitis, Anuria, Haematoma, Anaemia, Pancytopenia, Toxicity To Various Agents, Renal Failure Chronic, Pneumonia Bacterial, Rash Erythematous, Sepsis, Acute Hepatic Failure, Leukocytosis
Adverse event resulted in: death, hospitalization
Drug(s) suspected as cause:
Neulasta
Indication: Leukocytosis
Neupogen
Dosage: unk
Indication: Leukopenia
Start date: 2010-07-10
Neupogen
Indication: Leukocytosis
Neulasta
Dosage: 6 mg, unk
Indication: Leukopenia
Start date: 2010-07-12
End date: 2010-07-17
Other drugs received by patient: Cortisone Acetate; Eunerpan; Methotrexate; Vancomycin
Possible Neulasta side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-26
Patient: 71 year old male, weighing 36.2 kg (79.5 pounds)
Reactions: Electrocardiogram ST Segment Depression, White Blood Cell Count Decreased, Blood Urea Increased, Ventricular Hypokinesia, Anaemia, Diastolic Dysfunction, Systolic Dysfunction, Sepsis, Coronary Artery Occlusion, Arteriosclerosis Coronary Artery, Thrombocytopenia, Blood Creatinine Increased, Myocardial Infarction, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg milligram(s), subcutaneous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-02
Cyclophosphamide
Dosage: 1410 mg milligram(s), intravenous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Gemcitabine Hydrochloride
Dosage: 1880 mg milligram(s), intravenous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-01
Prednisone TAB
Dosage: 100 mg milligram(s), oral
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-29
(Rituximab)
Dosage: 705 mg milligram(s), intravenous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Vincristine Sulfate
Dosage: 2 mg milligram(s), intravenous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Other drugs received by patient: Metoclopramide; Tramadol HCL; Cotrim
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-04-26
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Dizziness, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Prednisolone
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Other drugs received by patient: Sulphamethizole; Omeprazole; Pinex; Valacyclovir Hydrochloride
Possible Neulasta side effects in male
Reported by a physician from Germany on 2012-04-23
Patient: male
Reactions: Anaemia, Platelet Count Decreased, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Mabthera
Dosage: 750 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-02
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Prednisolone
Dosage: 500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-02
End date: 2012-04-06
Vincristine
Dosage: 2 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Neulasta
Dosage: unk
Indication: B-Cell Lymphoma
Start date: 2012-04-06
End date: 2012-04-06
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: B-Cell Lymphoma
Start date: 2012-04-03
End date: 2012-04-03
Other drugs received by patient: Acyclovir; Dipyrone TAB; MST-30; Novalgin / 00169801 /; Pantozol / 01263204 /; Paspertin / 00041902 /
Possible Neulasta side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-04-20
Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)
Reactions: Anaemia, Pyrexia, Dyspnoea Exertional, Fatigue, Sepsis, Chest Pain, Thrombocytopenia, Myocardial Infarction, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Prednisone TAB
Dosage: 100 mg
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-29
Neulasta
Dosage: 6 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-02
Vincristine
Dosage: 2 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Cyclophosphamide
Dosage: 1410 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Gemcitabine
Dosage: 1880 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-01
Rituximab
Dosage: 705 mg
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Other drugs received by patient: Metoclopramide; Cotrim; Aspirin; Tramadol HCL
Possible Neulasta side effects in male
Reported by a physician from Germany on 2012-04-19
Patient: male
Reactions: Anaemia, Febrile Neutropenia, Platelet Count Decreased
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cyclophosphamide
Dosage: 1500 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-03
End date: 2012-04-03
Neulasta
Dosage: unk
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-06
End date: 2012-04-06
Doxorubicin HCL
Dosage: 100 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-03
End date: 2012-04-03
Vincristine
Dosage: 2 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-03
End date: 2012-04-03
Prednisolone
Dosage: 500 mg, qd
Indication: Product Used FOR Unknown Indication
Start date: 2012-04-02
End date: 2012-04-06
Other drugs received by patient: Novalgin / 00169801 /; MST-30; Acyclovir; Pantozol / 01263204 /; Mabthera; Paspertin / 00041902 /
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-04-19
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Fatigue, Malaise, Diarrhoea, Anaemia, Febrile Neutropenia, Dizziness
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Other drugs received by patient: Pinex; Omeprazole; Valacyclovir Hydrochloride; Sulphamethizole
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-04-12
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Diarrhoea, Anaemia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Other drugs received by patient: Sulphamethizole; Omeprazole; Codeine SUL TAB; Valacyclovir Hydrochloride
Possible Neulasta side effects in
Reported by a physician from Greece on 2012-04-09
Patient: , weighing 40.0 kg (88.0 pounds)
Reactions: Anaemia, Bone Pain, Febrile Neutropenia, Neutropenia, Thrombocytopenia
Drug(s) suspected as cause:
Neulasta
Possible Neulasta side effects in 47 year old male
Reported by a physician from United Kingdom on 2012-04-04
Patient: 47 year old male, weighing 107.0 kg (235.4 pounds)
Reactions: Fatigue, Anaemia, Neutropenia, Thrombocytopenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Neulasta
Other drugs received by patient: Levomepromazine; Fluconazole; Cisplatin; Gemcitabine; Ondansetron; Ifosfamide; Paclitaxel; Domperidone; Omeprazole
Possible Neulasta side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-30
Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)
Reactions: Electrocardiogram ST Segment Depression, Ventricular Hypokinesia, Platelet Count Increased, Pyrexia, Dyspnoea Exertional, Fatigue, Coronary Artery Occlusion, Chest Pain, Thrombocytopenia, Myocardial Infarction, Blood Creatinine Increased, White Blood Cell Count Decreased, Blood Urea Increased, Anaemia, Coronary Artery Disease, Troponin Increased, Sepsis, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Gemcitabine
Dosage: 1880 mg, intravenous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-01
Cyclophosphamide
Dosage: 1410 mg, intravenous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Neulasta
Dosage: 6 mg, subcutaneous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-29
Vincristine
Dosage: 2 mg, intravenous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Rituximab (Rituximab)
Dosage: 705 mg, intravenous
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Prednisone TAB
Dosage: 100 mg, oral
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-29
Other drugs received by patient: Trimethoprim + Sulfamethoxazole; Tramadol HCL; Metoclopramide
Possible Neulasta side effects in 71 year old male
Reported by a health professional (non-physician/pharmacist) from United Kingdom on 2012-03-28
Patient: 71 year old male, weighing 79.7 kg (175.3 pounds)
Reactions: Anaemia, Pyrexia, Dyspnoea Exertional, Hypokinesia, Fatigue, Chest Pain, Sepsis, Arterial Occlusive Disease, Thrombocytopenia, Myocardial Infarction, Infection
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Rituximab
Dosage: 705 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Gemcitabine
Dosage: 1880 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-01
Cyclophosphamide
Dosage: 1410 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Neulasta
Dosage: 6 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-04-02
Tramadol HCL
Dosage: 100 mg, unk
Administration route: Oral
Indication: Analgesic Therapy
Start date: 2009-03-25
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-29
Vincristine
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2009-03-25
End date: 2009-03-25
Other drugs received by patient: Metoclopramide; Aspirin; Cotrim
Possible Neulasta side effects in 77 year old male
Reported by a physician from Denmark on 2012-03-26
Patient: 77 year old male, weighing 97.0 kg (213.4 pounds)
Reactions: Diarrhoea, Anaemia, Febrile Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Neulasta
Dosage: 6 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-26
Vincristine
Dosage: 2 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Doxorubicin HCL
Dosage: 107 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Prednisone TAB
Dosage: 100 mg, unk
Administration route: Oral
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Cyclophosphamide
Dosage: 1612 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Rituximab
Dosage: 750 mg, unk
Indication: Diffuse Large B-Cell Lymphoma
Start date: 2011-03-25
Other drugs received by patient: Omeprazole; Codeine SUL TAB; Valacyclovir Hydrochloride; Sulphamethizole
Possible Neulasta side effects in 60 year old male
Reported by a physician from Romania on 2012-03-23
Patient: 60 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 120 mg, per chemo regim
Start date: 2012-02-07
Neulasta
Dosage: 6 mg, after chemo
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-11
Fluorouracil
Dosage: 1250 mg, 5 times/wk
Start date: 2012-02-06
End date: 2012-02-10
Taxotere
Dosage: 120 mg, per chemo regim
Start date: 2012-02-07
End date: 2012-02-07
Other drugs received by patient: Cisplatin; Fluorouracil; Taxotere
Possible Neulasta side effects in 54 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-07
Patient: 54 year old female, weighing 68.1 kg (149.7 pounds)
Reactions: White Blood Cell Count Decreased, Anaemia, Platelet Count Decreased, Febrile Neutropenia
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Abraxane
Dosage: 80 milligram/sq. meter
Start date: 2011-10-13
Carboplatin
Dosage: 6 dosage forms
Indication: Breast Cancer
Start date: 2011-08-11
Doxorubicin HCL
Dosage: 60 milligram/sq. meter
Indication: Breast Cancer
Start date: 2011-11-10
Cyclophosphamide
Dosage: 600 milligram/sq. meter
Indication: Breast Cancer
Start date: 2011-11-10
Abraxane
Dosage: 80 milligram/sq. meter
Indication: Breast Cancer
Start date: 2011-08-11
End date: 2011-10-06
Neulasta
Indication: Chemotherapy
Bevacizumab
Dosage: 10 milligram/kilogram
Indication: Breast Cancer
Start date: 2011-08-11
Possible Neulasta side effects in 60 year old male
Reported by a physician from Romania on 2012-03-05
Patient: 60 year old male, weighing 60.0 kg (132.0 pounds)
Reactions: Anaemia, Thrombocytopenia, Leukopenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Cisplatin
Dosage: 120 mg, per chemo regim
Start date: 2012-02-07
Taxotere
Dosage: 120 mg, per chemo regim
Start date: 2012-02-07
End date: 2012-02-07
Fluorouracil
Dosage: 1250 mg, 5 times/wk
Start date: 2012-02-06
End date: 2012-02-10
Neulasta
Dosage: 6 mg, after chemo
Indication: Product Used FOR Unknown Indication
Start date: 2012-02-11
Other drugs received by patient: Fluorouracil; Taxotere; Cisplatin
Possible Neulasta side effects in 31 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-02
Patient: 31 year old male
Reactions: Pneumonia, Syncope, Fatigue, Anaemia, Hypotension, Neutropenia
Adverse event resulted in: hospitalization
Drug(s) suspected as cause:
Methotrexate
Dosage: 420 mg, unk
Indication: non-Hodgkin's Lymphoma
Vincristine
Dosage: 2 mg, unk
Indication: non-Hodgkin's Lymphoma
Rituxan
Dosage: 788 mg, unk
Indication: non-Hodgkin's Lymphoma
Start date: 2011-09-07
Doxorubicin HCL
Dosage: 103 mg, unk
Indication: non-Hodgkin's Lymphoma
Neulasta
Dosage: 6 mg, unk
Indication: Product Used FOR Unknown Indication
Cytarabine
Dosage: 6.3 g, unk
Indication: non-Hodgkin's Lymphoma
Cyclophosphamide
Dosage: 618 mg, unk
Indication: non-Hodgkin's Lymphoma
Leucovorin Sodium
Dosage: 50 mg, unk
Administration route: Oral
Indication: Product Used FOR Unknown Indication
Mesna
Dosage: 1236 mg, unk
Indication: non-Hodgkin's Lymphoma
Dexamethasone
Dosage: 40 mg, unk
Indication: non-Hodgkin's Lymphoma
Other drugs received by patient: Ciprofloxacin; Valtrex; Medrol; Fluconazole; Voriconazole; Protonix
Possible Neulasta side effects in 44 year old female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-02-01
Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)
Reactions: White Blood Cell Count Decreased, Diarrhoea, Lymphatic Disorder, Anaemia, Platelet Count Decreased, Febrile Neutropenia, Cardiac Disorder
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Bevacizumab
Dosage: 10 milligram/kilogram
Indication: Breast Cancer
Start date: 2011-03-24
Doxorubicin HCL
Dosage: 10 milligram/sq. meter
Start date: 2011-03-24
Cyclophosphamide
Dosage: 600 milligram/sq. meter
Indication: Breast Cancer
Start date: 2011-03-24
Abraxane
Dosage: 80 milligram/sq. meter
Indication: Breast Cancer
Start date: 2011-03-24
Neulasta
Dosage: 6 milligram
End date: 2011-08-25
Other drugs received by patient: Metoprolol Tartrate; Famotidine; Guaifenesin; Zolpidem; Cefepime; Fluconazole; Prochlorperazine; Bacitracin; Whole Blood; Benzonatate; Acetaminophen
Possible Neulasta side effects in 44 year old female
Reported by a physician from United States on 2012-01-30
Patient: 44 year old female, weighing 119.6 kg (263.1 pounds)
Reactions: White Blood Cell Count Decreased, Type 2 Diabetes Mellitus, Lymphatic Disorder, Anaemia, Pancytopenia, Febrile Neutropenia, Cardiac Disorder, Diarrhoea, Platelet Count Decreased
Adverse event resulted in: life threatening event, hospitalization
Drug(s) suspected as cause:
Doxorubicin HCL
Dosage: 10 milligram/kilogram
Indication: Breast Cancer
Start date: 2011-03-24
Neulasta
Dosage: 6 milligram
Indication: Breast Cancer
End date: 2011-08-25
Abraxane
Dosage: 80 milligram/kilogram
Indication: Breast Cancer
Start date: 2011-03-24
Bevacizumab
Dosage: 10 milligram/kilogram
Indication: Breast Cancer
Start date: 2011-03-24
Cyclophosphamide
Dosage: 600 milligram/kilogram
Indication: Breast Cancer
Start date: 2011-03-24
Other drugs received by patient: Ambien; Pepcid; Mucinex; Tessalon; Toprol-XL; Bacitracin; Prochlorperazine; Armodafinil; Acetaminophen; Cefepime
Page 1 Next >>
|